Invention Grant
- Patent Title: 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases
-
Application No.: US17068985Application Date: 2020-10-13
-
Publication No.: US11111217B2Publication Date: 2021-09-07
- Inventor: Samuel D. Banister , Edgar Engleman , Khoa D. Nguyen , Mark Smith
- Applicant: The Board of Trustees of the Leland Stanford Junior University
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Heslin Rothenberg Farley & Mesiti, P.C.
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; C07D235/08
Abstract:
The compound 2-(4-tert-Butylphenyl)-1H-benzo[d]imidazol-5-ol: and its use are disclosed. The compound activates Ppargc1a and, as a consequence, is useful for treating neuroinflammation and for treating a variety of neurodegenerative diseases.
Public/Granted literature
- US20210061769A1 2-ARYLBENZIMIDAZOLES AS PPARGC1A ACTIVATORS FOR TREATING NEURODEGENERATIVE DISEASES Public/Granted day:2021-03-04
Information query
IPC分类:
